What's new? Log in Free sign up

Filing search / Olema Pharmaceuticals, Inc. / "Purpose"

Search information

Olema Pharmaceuticals, Inc.

Companies

"Purpose"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

83 results

Newest first Best match first

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

with a “*”. Depository AC # Financial Institution Account Type (Depository / Securities) Last Month Ending Account Balance Purpose of Account BORROWER Name/Address: SUBSIDIARY Name/Address Guarantor Name/Address

6 Aug 24

4:15pm

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

common shares. For purpose of this calculation, outstanding stock options, including unvested early exercised options, unvested restricted stock awards … , irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right, under certain limited

6 Aug 24

4:15pm

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

, Cambridge, MA 02139 (“Novartis”). WHEREAS, Olema and Novartis (each, a “Party” and collectively, the “Parties”) entered into the Agreement for the purpose

8 May 24

4:15pm

OLMA Olema Pharmaceuticals, Inc.

Quarterly report

potential dilutive common shares. For purpose of this calculation, outstanding stock options, including unvested early exercised options, unvested restricted … , irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right, under certain limited

8 May 24

4:15pm

OLMA Olema Pharmaceuticals, Inc.

Definitive proxy

for a legally valid purpose. If you would like to view the list, please contact us to schedule an appointment by emailing ir@olema.com. Where can I get … purpose of the Audit Committee is to discharge the responsibilities of our Board of Directors with respect to our corporate accounting and financial

26 Apr 24

5:07pm

Registration of securities for employees

v9sn5iksxr6w8g8cvie

11 Mar 24

4:15pm

11 Mar 24

4:15pm

11 Mar 24

4:15pm

Prospectus supplement

Shelf registration

31 Jan 24

4:21pm

Entry into a Material Definitive Agreement

Prospectus supplement for primary offering

Quarterly report

7 Nov 23

4:12pm

Olema Oncology Announces Expansion of Collaboration

yjlyja vmbvcqt4o

Olema Oncology Announces Combined Financing for Up to $180 Million

Olema Oncology Announces Combined Financing for Up to $180 Million

Olema Oncology Announces Combined Financing for Up to $180 Million

Quarterly report

8 Aug 23

4:12pm

Quarterly report

9 May 23

4:08pm

Prev
1
2
3
4
5
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.